Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to -$2.3 million.

  • Phibro Animal Health's Change in Receivables fell 10666.78% to -$2.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $15.7 million, marking a year-over-year decrease of 6775.4%. This contributed to the annual value of $55.2 million for FY2025, which is 53618.35% up from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's Change in Receivables is -$2.3 million, which was down 10666.78% from -$11.4 million recorded in Q3 2025.
  • Phibro Animal Health's Change in Receivables' 5-year high stood at $35.0 million during Q4 2024, with a 5-year trough of -$22.3 million in Q3 2022.
  • Its 5-year average for Change in Receivables is $4.5 million, with a median of $5.5 million in 2022.
  • As far as peak fluctuations go, Phibro Animal Health's Change in Receivables tumbled by 41102.22% in 2022, and later skyrocketed by 781986.3% in 2024.
  • Phibro Animal Health's Change in Receivables (Quarter) stood at $2.9 million in 2021, then skyrocketed by 154.85% to $7.5 million in 2022, then plummeted by 120.44% to -$1.5 million in 2023, then surged by 2379.41% to $35.0 million in 2024, then plummeted by 106.67% to -$2.3 million in 2025.
  • Its Change in Receivables stands at -$2.3 million for Q4 2025, versus -$11.4 million for Q3 2025 and $26.0 million for Q2 2025.